Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 6511 to 6525 of 8900 results

  1. Preterm labour and birth - timing of cord clamping

    Discontinued Reference number: GID-NG10396

  2. Intrapartum care for healthy women and babies - angle of episiotomy

    Discontinued Reference number: GID-NG10394

  3. Intrapartum care for healthy women and babies - rectal examination after delivery

    Discontinued Reference number: GID-NG10395

  4. Endometriosis: diagnosis and management - surgical management - pain management post-surgery

    Discontinued Reference number: GID-NG10385

  5. Conjunctivitis: antimicrobial prescribing

    Discontinued Reference number: GID-NG10166

  6. Blepharitis: antimicrobial prescribing

    Discontinued Reference number: GID-NG10168

  7. Stye: antimicrobial prescribing

    Discontinued Reference number: GID-NG10167

  8. Skin abscess: antimicrobial prescribing

    Discontinued Reference number: GID-NG10163

  9. Evobrutinib for treating relapsing multiple sclerosis [ID6313]

    Discontinued Reference number: GID-TA11357

  10. Nivolumab with ipilimumab for untreated unresectable metastatic oesophageal squamous cell carcinoma ID1629

    Discontinued Reference number: GID-TA10841

  11. Nitazoxanide for treating the common cold in people 12 years and over [ID4049]

    In development Reference number: GID-TA11128 Expected publication date: TBC

  12. Aumolertinib for untreated EGFR mutation-positive non-small-cell lung cancer [ID4000]

    In development Reference number: GID-TA10899 Expected publication date: TBC

  13. Housing: planning to improve health and wellbeing

    Discontinued Reference number: GID-NG10053

  14. Oral semaglutide for managing overweight and obesity [ID6188]

    Discontinued Reference number: GID-TA11149

  15. Spesolimab for preventing generalised pustular psoriasis flares [ID6216]

    In development Reference number: GID-TA11189 Expected publication date: TBC